Issue 73, 2024

Long-wavelength triggered iridium(iii) complex nanoparticles for photodynamic therapy against hypoxic cancer

Abstract

A long-wavelength triggered cationic iridium(III) complex, Ir5, and its corresponding nanoparticles with the ability to generate type I and type II reactive oxygen species have been synthesised. The complex targets mitochondria and achieves an excellent photodynamic therapy effect in hypoxic cancer cells.

Graphical abstract: Long-wavelength triggered iridium(iii) complex nanoparticles for photodynamic therapy against hypoxic cancer

Supplementary files

Article information

Article type
Communication
Submitted
13 Jul 2024
Accepted
12 Aug 2024
First published
22 Aug 2024
This article is Open Access
Creative Commons BY license

Chem. Commun., 2024,60, 9938-9941

Long-wavelength triggered iridium(III) complex nanoparticles for photodynamic therapy against hypoxic cancer

S. Liu, Z. Wang, Z. Wu, H. Chen, D. Zhu, G. Li, M. Yan, M. R. Bryce and Y. Chang, Chem. Commun., 2024, 60, 9938 DOI: 10.1039/D4CC03501A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements